Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-type proton ATPase subunit B, kidney isoform (ATP6V1B1) is the non-catalytic B1 subunit of the cytosolic V1 sector of vacuolar ATPase (V-ATPase), a multisubunit enzyme complex responsible for proton (H+) transport across intracellular organelle membranes and, in some cells, across the plasma membrane. This acidification is essential for processes such as urinary acidification in the kidney, protein sorting, endocytosis, synaptic vesicle function, and maintenance of pH in the inner ear. The B1 subunit is primarily expressed in the kidney and inner ear. Mutations in ATP6V1B1 disrupt normal acid-base homeostasis and are causative for distal renal tubular acidosis associated with progressive sensorineural hearing loss[1][2][3][7].
Drugs targeting this enzyme would likely inhibit or modulate ATPase-mediated proton transport, interfering with organellar and urinary acidification, but clinically relevant inhibitors are not listed; no approved drugs known to target specifically ATP6V1B1 in humans[2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-type proton ATPase subunit B, kidney isoform (ATP6V1B1).